India, Nov. 12 -- Novo Nordisk India has announced a significant price reduction for all strengths of Wegovy(R). This is a proactive measure by the company to make this critical obesity medication more accessible to a larger section of people living with obesity & overweight in India. As a benefit passed on to patients, thestarting dose of Wegovy(R)(0.25 mg) will now be available at an effective weekly price of Rs 2,712.

Wegovy(R)was launched pan-India asa once-weekly innovative FlexTouch(R)device in five dose strengths- 0.25 mg, 0.5 mg, 1 mg, 1.7 mg & 2.4 mg - in June 2025.It is thefirst and onlyobesity medication for people with overweight or obesity in India indicated for bothchronic weight managementandreduction in cardiovascular ris...